Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Report of unscheduled material events or corporate event

8-K
Current Reports
0001096906-03-000168.pdf 0001096906-03-000168.rtf View HTML

Annual report filed by small businesses

10KSB
Annual Filings
0001096906-03-000153.pdf 0001096906-03-000153.rtf 0001096906-03-000153.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001096906-03-000087.pdf 0001096906-03-000087.rtf 0001096906-03-000087.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001096906-03-000013.pdf 0001096906-03-000013.rtf View HTML

Quarterly report filed by small businesses

10QSB
Quarterly Filings
0001096906-02-000877.pdf 0001096906-02-000877.rtf 0001096906-02-000877.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
STONE WILLIAM B 0001096906-02-000785.pdf 0001096906-02-000785.rtf 0001096906-02-000785.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
SHORR ROBERT G L 0001096906-02-000789.pdf 0001096906-02-000789.rtf 0001096906-02-000789.xls View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Pearce Alan M 0001096906-02-000783.pdf 0001096906-02-000783.rtf 0001096906-02-000783.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
STEPHENSON L M 0001096906-02-000787.pdf 0001096906-02-000787.rtf 0001096906-02-000787.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001096906-02-000777.pdf 0001096906-02-000777.rtf 0001096906-02-000777.xls View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon